Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

The pursuit of optimal semaglutide dosing in type 2 diabetes continues. | Pepdox

Home
Search
PMID 37385277

The pursuit of optimal semaglutide dosing in type 2 diabetes continues.

Lancet (London, England)2023PMID: 37385277

View on PubMed DOI: 10.1016/S0140-6736(23)01233-3

Authors

Sherrill, Christina H; Hwang, Andrew Y